Company profile
NDT Pharmaceuticals Inc.
OTC: NDTP · Healthcare · Biotechnology
PublicHQ Vienna, VACIK 0001329944Reports USD
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 66
v0.1 · 5/100 weight · pillars only
↑ Altman-Z, listing tenure · ↓ filing timeliness, Piotroski F
Methodology →Revenue TTM
$278.5k
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
—
Employees
—
as of 2026-09-17
Market cap
$62.0M
as of 2026-09-17
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
No filed financials — private or non-XBRL filer.
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is NDT Pharmaceuticals Inc.’s financial profile?
NDT Pharmaceuticals Inc. has no structured financials on file — private or non-XBRL filer.
Peers · Healthcare
BioStem Technologies, Inc.——Sangamo Therapeutics, Inc.——Boundless Bio, Inc.——MiNK Therapeutics, Inc.——PDS Biotechnology Corporation——MindWalk Holdings Corp.——Key facts
CEOJames Hovis
SectorHealthcare
IndustryBiotechnology
HeadquartersVienna, VA
ExchangeOTC: NDTP
Employees—
IPO date2008-01-22
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.